Safeguarding The Bioeconomy

Research and innovation in the life sciences is driving rapid growth in agriculture, biomedical science, information science and computing, energy, and other sectors of the U.S. economy. This economic activity, conceptually referred to as the bioeconomy, presents many opportunities to create jobs, improve the quality of life, and continue to drive economic growth. While the United States has been a leader in advancements in the biological sciences, other countries are also actively investing in and expanding their capabilities in this area. Maintaining competitiveness in the bioeconomy is key to maintaining the economic health and security of the United States and other nations. Safeguarding the Bioeconomy evaluates preexisting and potential approaches for assessing the value of the bioeconomy and identifies intangible assets not sufficiently captured or that are missing from U.S. assessments. This study considers strategies for safeguarding and sustaining the economic activity driven by research and innovation in the life sciences. It also presents ideas for horizon scanning mechanisms to identify new technologies, markets, and data sources that have the potential to drive future development of the bioeconomy.

This book is open access under a CC BY 4.0 license. This book defines the new field of "Bioeconomy" as the sustainable and innovative use of biomass and biological knowledge to provide food, feed, industrial products, bioenergy and ecological services. The chapters highlight the importance of bioeconomy-related concepts in public, scientific, and political discourse. Using an interdisciplinary approach, the authors outline the dimensions of the bioeconomy as a means of achieving sustainability. The authors are ideally situated to elaborate on the diverse aspects of the bioeconomy. They have acquired in-depth experience of interdisciplinary research through the university’s focus on “Bioeconomy”, its contribution to the Bioeconomy Research Program of the federal state of Baden-Württemberg, and its participation in the German Bioeconomy Council. With the number of bioeconomy-related projects at European universities rising, this book will provide graduate students and researchers with background information on the bioeconomy. It will familiarize scientific readers with bioeconomy-related terms and give scientific background for economists, agronomists and natural scientists alike.

This book demonstrates that a holistic approach to the bioeconomy is essential if it is to achieve its full potential in driving economic growth while simultaneously providing ecological, social and technological benefits. Definitions of the ‘bioeconomy’ vary but in general it incorporates the ways in which societies manage and distribute their primary or secondary biological resources for further use in everyday life (e.g. food, materials, and energy). The classical sectors related to the bioeconomy have therefore been agriculture, forestry and aquaculture, now extended to include bioenergy, biofuels, biochemicals, and other processing and service industries. There are also related new concepts such us the blue economy, the green economy, and the circular economy. This book integrates these definitions, sectoral analyses and new concepts into a fully rounded study of the bioeconomy. It is argued that the key aims in the coming years have to be the harmonization of public policies between different sectors, regulation of legislative framework for the bioeconomy, and clear communication of these issues. In particular, the book argues that a strengthening of the monitoring and evaluation of the impacts of the bioeconomy on society is an essential starting point. For this to be effective, appropriate indicators need to be established and defined for the monitoring of the effects of these resilient policies related to bioeconomy and their impact on local and regional development and quality of life. This book will be essential reading for anyone interested in the bioeconomy including students and scholars of ecological economics, environmental economics, sustainability, innovation, and regional development.

This book explores the evolution of the current U.S. research and development enterprise, asks whether this organization remains appropriate to the challenges we face today, and proposes strategies for better preparing for the global technology race shaping our future. Across the globe, nation states and societies, as well as corporations, technology developers, and even individuals, find themselves on the front lines of a global technology race. As we approach the third decade of this century, the outlines of the contest have become clear. Spending on research and development, such new methods as innovation centers, and inclusion of powerful technologies into governments and society are occurring at a rapid pace. Technology winners and losers are emerging. How did we arrive at this global technology fight? How and where will it be waged? What can we do to prepare for the future? In 10 chapters, Tech Wars addresses these questions and more, examining the conditions that have led us to this point and introducing new strategies, organizational changes, and resource allocations that will help the United States respond to the challenges that are on the horizon.

Between 1973 and 2016, the ways to manipulate DNA to endow new characteristics in an organism (that is, biotechnology) have advanced, enabling the development of products that were not previously possible. What will the likely future products of biotechnology be over the next 5â€"10 years? What scientific capabilities, tools, and/or expertise may be needed by the regulatory agencies to ensure they make efficient and sound evaluations of the likely future products of biotechnology? Preparing for Future Products of Biotechnology analyzes the future landscape of biotechnology products and seeks to inform forthcoming policy making. This report identifies potential new risks and frameworks for risk assessment and areas in which the risks or lack of risks relating to the products of biotechnology are well understood.

Cyberbiosecurity applies cybersecurity research to the field of biology, and, to a lesser degree, applies biological principles to the field of cybersecurity. As biologists increasingly research, collaborate, and conduct research online, cyberbiosecurity has become crucial to protect against cyber threats. This book provides an overview of cyberbiosecurity through the lens of researchers in academia, industry professionals, and government, in both biology and cybersecurity fields. The book highlights emerging technologies, and identifies emerging threats connected with these technologies, while also providing a discussion of the legal implications involved. This book takes on a multidisciplinary approach, and appeals to both professionals and researchers in the synthetic biology, bioinformatics, and cybersecurity fields.

Global advances in medicine, food, water, energy, microelectronics, communications, defense, and other important sectors of the economy are increasingly driven by discoveries in nanoscience and the development of nanotechnologies. Engaging the nanoscience and technology community in the crafting of national priorities, developing novel approaches for translating fundamental discovery to a technology readiness level appropriate for venture/industry funding, increasing domestic student interest in nanoscience to expand the workforce pipeline, and exploring new ways of coordinating the work of the National Nanotechnology Initiative (NNI) are all imperatives if the United States is to fully reap the societal benefits of nanotechnology. A Quadrennial Review of the National Nanotechnology Initiative provides a framework for a redesign of the NNI and its coordination with the goal of achieving a U.S. resurgence in nanotechnology. This report makes recommendations to improve the value of the NNI's research and development strategy and portfolio to the economic prosperity and national security of the United States.

This book explores the ethical governance of Artificial Intelligence (AI) & Machine Learning (ML) in healthcare. AI/ML usage in healthcare as well as our daily lives is not new. However, the direct, and oftentimes long-term effects of current technologies, in addition to the onset of future innovations, have caused much debate about the safety of AI/ML. On the one hand, AI/ML has the potential to provide effective and efficient care to patients, and this sways the argument in favor of continuing to use AI/ML; but on the other hand, the dangers (including unforeseen future consequences of the further development of the technology) leads to vehement disagreement with further AI/ML usage. Due to its potential for beneficial outcomes, the book opts to push for ethical AI/ML to be developed and examines various areas in healthcare, such as big data analytics and clinical decision-making, to uncover and discuss the importance of developing ethical governance for AI/ML in this setting.